André Álcega Hartmann
Health Economics | Strategy | Pharma
About
I combine over a decade of clinical healthcare experience with formal training in health economics (EU-HEM: Bologna, Erasmus Rotterdam, Oslo) and hands-on pharmaceutical industry experience.
Since 2013, I have worked across the Norwegian healthcare system at every level: from municipal primary care in Oslo to specialist hospitals, from advanced elderly care in Bergen to emergency triage in Tromsø and remote care in Kautokeino. That breadth of frontline experience, across regions and specialties, means I understand how treatments work in practice, not just in models.
Having also coordinated health care services in Australia and New Zealand, and lived in 14 countries altogether, I have developed an ability to read between the lines, spot patterns others might miss, and identify where real improvements can be made. I see this as both a gift and a responsibility: to find the right place where my capacity for analytical thinking can add genuine value.
That perspective drew me from clinical delivery into health economics and market access. I wanted to understand how systems decide which treatments reach patients, and where rigorous evidence and strategic thinking can improve those decisions.
What I bring
- 10+ years in Norwegian clinical healthcare across primary care, specialist hospitals, and mental health services
- Economic evaluation, HTA methodology, and decision modelling (EU-HEM, three European universities)
- Pharmaceutical industry experience in market access, medical affairs, and health policy
- Hands-on AI deployment in pharma, including prompt engineering for regulated content and building tools for cross-functional teams
- Five languages and cross-cultural fluency from living and working in 14 countries
Current work
I drive practical AI adoption in the pharmaceutical industry, across functions from market access to medical affairs. I build tools, SOPs, and training that help pharmaceutical professionals integrate AI into regulated workflows.
In my independent academic work, my research includes a cost-utility analysis for my master's thesis and the resource criterion analysis published on this site, which examines 28 years of workforce capacity measurement in Norwegian HTA. This research was conducted during my time as a health economics student.
Contact
Open to opportunities in health economics, market access, pharma strategy, and consulting. Based in Oslo.